Physician profile
Scott Latimer Woodfield
NPI 1568455723
$22,268.98
in general payments reported to CMS, 2019-2025
59 companies · $4,293 in 2025
The $4,293 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,337 · 2020: $1,338 · 2021: $3,185 · 2022: $2,548 · 2023: $2,469 · 2024: $5,099 · 2025: $4,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $743 · Education: $13.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,104.28 |
| Travel and Lodging | $743.45 |
| Education | $13.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,395.75 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $1,447.87 | 2019-2025 | Avvigo Guidance System, Opticross, Comet |
| Cardiovascular Systems INC. | $1,243.26 | 2019-2023 | Diamondback Coronary |
| Amgen INC. | $1,173.21 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $1,158.58 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,018.47 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $983.99 | 2019-2025 | Eliquis, Camzyos |
| Medtronic, INC. | $905.95 | 2021-2025 | Symplicity G3, Onyx Frontier, Tyrx |
| Abbott Laboratories | $891.15 | 2019-2025 | Amplatzer Amulet, Cardiomems, Jot Dx |
| Astrazeneca Pharmaceuticals LP | $842.71 | 2019-2024 | Farxiga, Wainua, Andexxa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $762.16 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $633.37 | 2019-2025 | |
| Inari Medical, INC. | $597.87 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $575.12 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $463.04 | 2019-2025 | Onpattro, Amvuttra |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $457.50 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Atricure, INC. | $426.50 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atricure Cryoice Cryoablation System (Cryo2) |
| Cms Imaging, INC. | $411.41 | 2025 | |
| Medtronic Vascular, INC. | $354.24 | 2019-2020 | |
| Heartflow, INC. | $346.31 | 2019-2025 | |
| Biotronik INC. | $327.27 | 2019-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Biomonitor |
| Philips North America LLC | $301.47 | 2024-2025 | (Cm9) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided, (K95) Ecc Solutions |
| Esperion Therapeutics, INC. | $293.64 | 2020-2025 | Nexletol |
| Actelion Pharmaceuticals US, INC. | $274.57 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $250.01 | 2019-2024 | |
| Bridgebio Pharma, INC. | $234.71 | 2025 | Attruby |
| Siemens Medical Solutions USA, INC. | $229.11 | 2025 | Cios Flow |
| Scpharmaceuticals INC. | $213.60 | 2023-2025 | |
| Livanova USA, INC. | $192.10 | 2019 | |
| Stryker Corporation | $191.24 | 2025 | Ct Thrombectomy System Kit, Flowtriever, Clottriever Bold Catheter |
| Abiomed | $165.04 | 2024-2025 | Impella |
| Kiniksa Pharmaceuticals, LTD. | $150.33 | 2021-2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $142.03 | 2019-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $135.34 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $126.76 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $121.18 | 2021-2025 | Verquvo |
| United Therapeutics Corporation | $81.69 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $76.45 | 2024 | Crosser Iq |
| Novo Nordisk INC | $73.72 | 2024-2025 | Wegovy |
| Astellas Pharma US INC | $66.95 | 2019-2020 | |
| Akcea Therapeutics, INC. | $64.37 | 2020-2021 | |
| Cardinal Health 200 LLC | $55.42 | 2019 | |
| Cardiva Medical, INC. | $52.17 | 2025 | Savvywire |
| Irhythm Technologies, INC. | $41.93 | 2024 | Zio Xt Patch, Zio Monitor |
| Vital Connect, INC | $39.98 | 2025 | Vitalpatch Rtm |
| Terumo Medical Corporation | $37.81 | 2019-2025 | Metacross Otw, Azur Cx Detachable, Glidewire |
| Bayer Healthcare Pharmaceuticals INC. | $35.29 | 2025 | |
| Impulse Dynamics (USA) INC. | $29.30 | 2023 | Optimizer |
| Angiodynamics, INC. | $25.58 | 2025 | Alphavac |
| Daiichi Sankyo INC. | $20.95 | 2024 | Injectafer |
| Teleflex LLC | $20.91 | 2024 | Twin-Pass |
| Lundbeck LLC | $17.91 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $17.00 | 2024 | |
| Cvrx, INC. | $15.88 | 2022 | |
| Reflow Medical INC | $15.59 | 2024 | |
| Aegerion Pharmaceuticals, INC. | $15.11 | 2019 | |
| Cashflow Solutions, LLC | $10.34 | 2024 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Bardy Diagnostics, INC. | $10.00 | 2020 | |
| Thrombolex, INC. | $7.77 | 2025 | Bashir Endovascular Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Woodfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.